InvestorsHub Logo

rosemountbomber

05/06/22 4:09 PM

#376872 RE: HDGabor #376869

HD, sorry if this has already been asked of you. Do you have an opinion as to whether the UK will approve some sort of reimbursement for Vazkepa or deny it completely? TIA

Whalatane

05/06/22 5:33 PM

#376889 RE: HDGabor #376869

Not sure why you're so fixated on Sweden . Its a relatively small market ( 10.4 million ) compared to Germany ..over 83 million .( total populations )
Economic headwinds


BERLIN, March 30 (Reuters) - The German government's council of economic advisers more than halved its growth forecast for Europe's largest economy on Wednesday and flagged a "substantial" recession risk as a result of Russia's invasion of Ukraine.

The advisers, whose forecasts guide the German government in setting fiscal policy, cut their 2022 economic growth forecast to 1.8% from 4.6%, adding output would not reach its pre-pandemic level before the third quarter of the year.



Last I looked Sweden was expecting to still grow by 3% this year .
The new WAC to be agreed on this year between Germany and AMRIN will IMHO be significantly lower than what AMRN currently receives ...so how does that not affect margins for at least that market ...the largest in the EU

AMRN appears to be increasing rebates in the US which will also lower margins .
Re formularies ...I'll defer to poster Duke on those as he's spent more time navigating them then I ever want to.

U raised an important pt regarding AMRN purchasing contracts. They can keep this to the minimum , thus work off inventory and reduce cash burn

Kiwi